This Article Full Text Full Text (PDF) All Versions of this Article: 34/12/2945    most recent 01.STR.0000103137.44496.ADv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Camilo, O. Articles by Goldstein, L. B. Search for Related Content PubMed PubMed Citation Articles by Camilo, O. Articles by Goldstein, L. B. Related Collections Thrombolysis Carotid endarterectomy Acute Cerebral Infarction Emergency treatment of Stroke Primary and Secondary Stroke Prevention

(Stroke. 2003;34:2945.)
© 2003 American Heart Association, Inc.

Original Contributions

Statewide Assessment of Hospital-Based Stroke Prevention and Treatment Services in North Carolina

Changes Over the Last 5 Years

From the Department of Medicine (Neurology) (O.C., L.B.G.), Duke Center for Cerebrovascular Disease (O.C., L.B.G.), and Stroke Policy Program, Center for Clinical Health Policy Research (L.B.G.), Duke University, and the Durham VA Medical Center (L.B.G.), Durham, NC.

Correspondence to Larry B. Goldstein, MD, Director, Duke Center for Cerebrovascular Disease, Head, Stroke Policy Program, Center for Clinical Health Policy Research, Box 3651, Duke University Medical Center, Durham, NC 27710. E-mail golds004{at}mc.duke.edu

Background and Purpose— The first published statewide assessment of stroke prevention and treatment services in the United States was carried out in North Carolina in 1998. The purpose of the present study was to measure changes in these services that may have occurred over the last 5 years.

Methods— A 1-page questionnaire was sent to each facility in the state in February 2003. Results were compared with the 1998 survey.

Results— Complete responses were obtained from each of the state’s 128 facilities. The proportions of hospitals providing CT angiography (35% versus 55%, P0.01), diffusion-weighted MRI (20% versus 45%, P0.01), transesophageal echocardiography (45% versus 59%, P0.02), and inpatient rehabilitation services (25% versus 43%, P0.01) increased over the 5 years. There was a trend toward more facilities having tissue plasminogen activator protocols (43% versus 54%, P0.09) but a decrease in the proportion of hospitals with interventional radiologists (23% versus 15%, P<0.01). There was no change in the proportion of the state’s population living in a county with a basic stroke prevention and treatment center, with the proportion residing in a county with an advanced center increasing by 12%. Entire regions of the state lacked either type of center, and only 14% had even the essential infrastructure recommended for a Brain Attack Coalition–type primary stroke center. There was no difference in the proportions of hospitals with organized stroke teams, those having a stroke acute care unit, those using stroke care maps, or hospitals having community awareness programs.

Conclusions— Certain technologies have become more widely available, but hospital investments in stroke-related programs have not appreciably increased.

Key Words: cerebrovascular disorders • data collection • diagnosis • emergency medical services • primary prevention • thrombolytic therapy

This article has been cited by other articles:

				D. C. Goff Jr, L. Brass, L. T. Braun, J. B. Croft, J. D. Flesch, F. G.R. Fowkes, Y. Hong, V. Howard, S. Huston, S. F. Jencks, et al. Essential Features of a Surveillance System to Support the Prevention and Management of Heart Disease and Stroke: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Stroke, and Cardiovascular Nursing and the Interdisciplinary Working Groups on Quality of Care and Outcomes Research and Atherosclerotic Peripheral Vascular Disease Circulation, January 2, 2007; 115(1): 127 - 155. [Full Text] [PDF]

				M. I. Weintraub Thrombolysis (Tissue Plasminogen Activator) in Stroke: A Medicolegal Quagmire Stroke, July 1, 2006; 37(7): 1917 - 1922. [Abstract] [Full Text] [PDF]

				G. L. Birbeck, D. S. Zingmond, X. Cui, and B. G. Vickrey Multispecialty stroke services in California hospitals are associated with reduced mortality Neurology, May 23, 2006; 66(10): 1527 - 1532. [Abstract] [Full Text] [PDF]

				L. B. Goldstein and D. L. Simel Is This Patient Having a Stroke? JAMA, May 18, 2005; 293(19): 2391 - 2402. [Abstract] [Full Text] [PDF]

				O. Camilo and L. B. Goldstein Lower stroke-related mortality in counties with stroke centers: North Carolina Stroke Facilities Survey Neurology, February 22, 2005; 64(4): 762 - 763. [Full Text] [PDF]

				February 8 Highlight and Commentary: Criteria for stroke centers Neurology, February 8, 2005; 64(3): 403 - 403. [Full Text] [PDF]

				V. Aiyagari, A. Gujjar, A. R. Zazulia, and M. N. Diringer Hourly Blood Pressure Monitoring After Intravenous Tissue Plasminogen Activator for Ischemic Stroke: Does Everyone Need It? Stroke, October 1, 2004; 35(10): 2326 - 2330. [Abstract] [Full Text] [PDF]